Proponent 发表于 2025-3-25 04:57:38

Brain iron and schizophrenia,and control subjects without neuropsychiatric diseases. Analysis of iron content showed a clear regional difference with highest iron levels in the caudate nucleus. There was no correlation between iron content and the neuroleptic-free period prior to death. Iron content in the schizophrenic group w

异教徒 发表于 2025-3-25 08:37:30

http://reply.papertrans.cn/48/4755/475410/475410_22.png

北京人起源 发表于 2025-3-25 15:22:10

http://reply.papertrans.cn/48/4755/475410/475410_23.png

奇怪 发表于 2025-3-25 19:54:26

http://reply.papertrans.cn/48/4755/475410/475410_24.png

larder 发表于 2025-3-25 20:22:13

http://reply.papertrans.cn/48/4755/475410/475410_25.png

ORE 发表于 2025-3-26 00:49:36

,Intranigral iron infusion in rats: A progressive model for excess nigral iron levels in Parkinson’sc may be a direct consequence of increased iron because of iron’s ability to catalyze cytotoxic free radical formation. We have developed an animal model based on excess nigral iron in PD through intranigral infusion of iron citrate in rats. These infusions cause a long-term and dose-related increas

Abominate 发表于 2025-3-26 04:34:10

http://reply.papertrans.cn/48/4755/475410/475410_27.png

山崩 发表于 2025-3-26 10:40:29

http://reply.papertrans.cn/48/4755/475410/475410_28.png

NAV 发表于 2025-3-26 13:42:32

Consequences of intrastriatally administrated FeCl3 and 6-OHDA without and after transient cerebralontralateral turning and rotations after apomorphine administration. Treatment with alpha-tocopherol prevents the hypersensitive reaction. The sensitivity of the cerebral tissue to apomorphine following 6-OHDA treatment is enhanced when 7.5 µg FeCl. is coadministered with 6-OHDA. Only when the combi

GRAVE 发表于 2025-3-26 19:11:58

http://reply.papertrans.cn/48/4755/475410/475410_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Iron in Central Nervous System Disorders; Peter Riederer,M. B. H. Youdim Conference proceedings 1993 Springer-Verlag/Wien 1993 Central Ner